title: A comparison of pregabalin and gabapentin in palliative care #289.
authors.forename: Jennifer
authors.initials: J
authors.lastname: Pruskowski
authors.forename: Robert M
authors.initials: RM
authors.lastname: Arnold
mesh_terms: D000588:Amines / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics / Q000493:pharmacokinetics*; D000700:Analgesics / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics / Q000493:pharmacokinetics; D001682:Biological Availability; D003365:Costs and Cost Analysis; D003509:Cyclohexanecarboxylic Acids / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics / Q000493:pharmacokinetics*; D000077206:Gabapentin; D006801:Humans; D010166:Palliative Care / Q000379:methods* / Q000592:standards; D000069583:Pregabalin / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics / Q000493:pharmacokinetics*; D005680:gamma-Aminobutyric Acid / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics / Q000493:pharmacokinetics*
chemical_list: D000588:Amines; D000700:Analgesics; D003509:Cyclohexanecarboxylic Acids; D000069583:Pregabalin; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin